Through CTC NGS, this study found that more than 50% of early lung cancer patients have 4 common mutated genes, namely NOTCH1, IGF2, EGFR and PTCH1. Also, 47.37% of patients have ARID1A mutations. Here, IGF2 is linked to lung cancer.